Evidence for asymptomatic microhematuria as a risk factor for the development of ESRD

American Journal of Kidney Diseases

Volumn 60, Issue 1, 2012, Pages 12-14

  Iseki, Kunitoshi ^a  

^a UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; FOLLOW UP; GLOMERULONEPHRITIS; HEMATURIA; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DONOR; KIDNEY FAILURE; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; URINALYSIS; URINE DIPSTICK;

EID: 84862609730     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.01.009     Document Type: Editorial

References (20)

1. Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012;379(9811):165- 180.
2. Li PK, Chow KM, Matsuo S, et al. Asian Chronic Kidney Disease (CKD) Best Practice Recommendations - positional statements for early detection of CKD from Asian Forum for CKD Initiatives (AFCKDI). Nephrology. 2011;16(7):633-641.
3. Vivante A, Afek A, Frenkel-Nir Y, et al. Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease. JAMA. 2011;306(7):729-736.
4. Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63(4):1468-1474.
5. Iseki K, Iseki C, Ikemiya Y, Fukiyama K. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int. 1996;49(3):800-805.
6. Yamagata K, Yamagata Y, Kobayashi M, Koyama A. A long-term follow-up study of asymptomatic hematuria and/or proteinuria in adults. Clin Nephrol. 1996;45(5):281-288.
7. Xie Y, Nishi S, Ueno M, et al. The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. Kidney Int. 2003;63(5):1861-1867.
8. US Renal Data System. Reference Tables: I. Patient survival. In: USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2009:671-716.
9. Nakai S, Masakane I, Shigematsu T, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2007). Ther Apher Dial. 2009;13(6):457-504.
10. Yamagata K, Takahashi H, Suzuki S, et al. Age distribution and yearly changes in the incidence of ESRD in Japan. Am J Kidney Dis. 2004;43(3):433-443.
11. Iseki K. Role of urinalysis in the diagnosis of chronic kidney disease (CKD). Jpn Med Assoc J. 2011;54(1):27-30.
12. Imai E, Yamagata K, Iseki K, et al. Kidney disease screening program in Japan; history, outcome, and perspectives. Clin J Am Soc Nephrol. 2007;2(6):1360-1366.
13. Iseki K. Chronic kidney disease in Japan: from early predictions to current facts. Nephron Clin Pract. 2008;110(4);c268-c272.
14. Brown RS. Has the time come to include urine dipstick testing in screening asymptomatic young adults? JAMA. 2011;306(7):764-765.
15. Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80(1):17-28.
16. The Japanese Society of Nephrology. CKD Practice Guide 2009 [in Japanese]. Tokyo, Japan: Tokyo Igakusha; 2009.
17. Yamagata K, Ishida K, Sairenchi T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71(2):159-166.
18. Kido R, Shibagaki Y, Iwadoh K, et al. How do living kidney donors develop end-stage renal disease? Am J Transplant. 2009;9(11):2514-2519.
19. Kido R, Shibagaki Y, Iwadoh K, et al. Persistent glomerular hematuria in living kidney donors confers a risk of progressive kidney disease in donors after heminephrectomy. Am J Transplant. 2010;10(7):1597-1604.
20. Yamagata K, Iseki K, Nitta K, et al. Chronic kidney disease perspective in Japan and the importance of urinalysis screening. Clin Exp Nephrol. 2008;12(1):1-8.